GlassScriptPhysician profile
Scott M Wilkinson
NPI 1184812992
$8,383.04
in general payments reported to CMS, 2019-2025
41 companies · $1,038 in 2025
The $1,038 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,987 · 2020: $580 · 2021: $682 · 2022: $945 · 2023: $1,083 · 2024: $1,067 · 2025: $1,038.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,089 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,088.53 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $2,192.33 | 2019-2025 | Porges Coloplast |
| Astellas Pharma US INC | $994.51 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Teleflex LLC | $764.71 | 2021-2023 | Urolift |
| Axonics, INC. | $493.58 | 2022-2024 | Axonics, Bulkamid |
| Ferring Pharmaceuticals INC. | $380.50 | 2019-2025 | Adstiladrin |
| Neotract INC. | $350.37 | 2019-2020 | |
| Antares Pharma, INC. | $330.74 | 2020-2025 | Xyosted, Nocdurna, Tlando |
| Medtronic, INC. | $322.97 | 2021-2025 | Interstim, Altaviva |
| Sumitomo Pharma America, INC. | $257.29 | 2024-2025 | Orgovyx, Gemtesa |
| Abbvie INC. | $247.14 | 2022-2025 | Botox |
| Tolmar, INC. | $219.98 | 2023-2025 | Jatenzo, Eligard |
| Dendreon Pharmaceuticals LLC | $190.03 | 2023 | Provenge |
| Pfizer INC. | $138.89 | 2019-2025 | |
| Boston Scientific Corporation | $137.46 | 2023-2025 | Axonics, Spaceoar Vue System - 10ml |
| Olympus America INC. | $124.39 | 2024-2025 | Itind System |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $118.74 | 2021-2025 | Prolaris |
| Allergan, INC. | $108.52 | 2019-2022 | |
| Urogen Pharma, INC. | $95.79 | 2023-2025 | Jelmyto |
| Merck Sharp & Dohme LLC | $87.17 | 2024-2025 | Keytruda, Keytruda Qlex |
| Endo Pharmaceuticals INC. | $83.37 | 2019-2023 | Xiaflex |
| Tolmar Pharmaceuticals, INC. | $82.45 | 2019-2022 | |
| Blue Earth Diagnostics | $65.29 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $59.05 | 2019-2024 | Pipeline, Erleada |
| Halozyme INC | $57.47 | 2023 | |
| Janssen Biotech, INC. | $52.89 | 2019-2023 | Erleada |
| Bioprotect Medical, INC. | $51.77 | 2024-2025 | Bioprotect Balloon Implant System |
| Amgen INC. | $46.89 | 2019-2020 | |
| Calyxo, INC. | $44.86 | 2024-2025 | Cvac Aspiration System |
| 180 Medical, INC. | $37.31 | 2019-2024 | Gentlecath Glide |
| Procept Biorobotics Corporation | $35.84 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $34.06 | 2023 | Bard Urinary Drainage Bag |
| Astrazeneca Pharmaceuticals LP | $31.75 | 2021 | |
| Integra Lifesciences Corporation | $24.40 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Immunitybio, INC. | $21.39 | 2025 | |
| Dompe US, INC. | $18.79 | 2021 | |
| Urovant Sciences INC | $14.56 | 2022 | |
| Sun Pharmaceutical Industries INC. | $14.28 | 2019 | |
| Medtronic USA, INC. | $13.67 | 2019 | |
| Clarus Therapeutics INC. | $13.09 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.02 | 2019 | |
| Rochester Medical Corporation | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Wilkinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.